Latest news
Novavax (NVAX) Is Up 8.6% After Beating Q2 Estimates And Expanding Big-Pharma Partnerships - What's Changed - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 10:10:04 GMTNVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 18:18:00 GMTNovavax, Inc. Stock 12‑Month Price Target Cut to $13.75, Implies 78% Upside - TradingViewTradingView · Fri, 07 Aug 2026 14:20:21 GMTNVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - StocktwitsStocktwits · Fri, 07 Aug 2026 08:03:49 GMTNVAX SWOT Analysis: Financial Challenges and Opportunities Revea - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:03:02 GMTNovavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:19:05 GMTNovavax, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:NVAX) 2026-08-06 - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 22:08:46 GMTNVAX Stock Holds Steady As Novavax Lifts Revenue Outlook On Licensing Pivot — Retail Eyes Buyout, More Partnership Deals - StocktwitsStocktwits · Thu, 06 Aug 2026 21:29:00 GMT